CTSE | Cathepsin E | Enzymes Predicted secreted proteins
| | | | | Group enriched |
CTSG | Cathepsin G | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CTSH | Cathepsin H | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CTSS | Cathepsin S | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CTSW | Cathepsin W | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CTSZ | Cathepsin Z | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
DAG1 | Dystroglycan 1 (dystrophin-associated glycoprotein 1) | Cytoskeleton related proteins Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
DNPEP | Aspartyl aminopeptidase | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
DPEP1 | Dipeptidase 1 (renal) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
DPEP3 | Dipeptidase 3 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
DPP4 | Dipeptidyl-peptidase 4 | CD markers Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DPP6 | Dipeptidyl-peptidase 6 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ECE1 | Endothelin converting enzyme 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ELANE | Elastase, neutrophil expressed | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
EPHX1 | Epoxide hydrolase 1, microsomal (xenobiotic) | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ERAP2 | Endoplasmic reticulum aminopeptidase 2 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
F2 | Coagulation factor II (thrombin) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
FOLH1 | Folate hydrolase (prostate-specific membrane antigen) 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GZMB | Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
GZMH | Granzyme H (cathepsin G-like 2, protein h-CCPX) | Enzymes Predicted secreted proteins
| | | | | Mixed |
GZMK | Granzyme K (granzyme 3; tryptase II) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
HGFAC | HGF activator | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
HP | Haptoglobin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
HPR | Haptoglobin-related protein | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
KLK10 | Kallikrein-related peptidase 10 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
KLK13 | Kallikrein-related peptidase 13 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
KLK2 | Kallikrein-related peptidase 2 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
KLK3 | Kallikrein-related peptidase 3 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
KLK4 | Kallikrein-related peptidase 4 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
KLK5 | Kallikrein-related peptidase 5 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
KLK7 | Kallikrein-related peptidase 7 | Cancer-related genes Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
KLK8 | Kallikrein-related peptidase 8 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
LACTB | Lactamase, beta | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
LAP3 | Leucine aminopeptidase 3 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
LGMN | Legumain | Cancer-related genes Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
LONP1 | Lon peptidase 1, mitochondrial | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
LPA | Lipoprotein, Lp(a) | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
LTA4H | Leukotriene A4 hydrolase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
MALT1 | Mucosa associated lymphoid tissue lymphoma translocation gene 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
MASP1 | Mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MBTPS1 | Membrane-bound transcription factor peptidase, site 1 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
MBTPS2 | Membrane-bound transcription factor peptidase, site 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
MEP1A | Meprin A, alpha (PABA peptide hydrolase) | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
MEP1B | Meprin A, beta | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
METAP2 | Methionyl aminopeptidase 2 | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MMP8 | Matrix metallopeptidase 8 (neutrophil collagenase) | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
MMP9 | Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NAALADL2 | N-acetylated alpha-linked acidic dipeptidase-like 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
NAPSA | Napsin A aspartic peptidase | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |